Results 241 to 250 of about 3,110,681 (290)
Some of the next articles are maybe not open access.
Current Opinion in Obstetrics and Gynecology, 1992
Although hormone replacement therapy (HRT) has been available for almost 100 years, conflicting opinions still exist about its efficacy and safety. There is uniform agreement that vasomotor instability and vaginal atrophy are totally reversible with HRT.
L E, Nachtigall, M J, Nachtigall
openaire +2 more sources
Although hormone replacement therapy (HRT) has been available for almost 100 years, conflicting opinions still exist about its efficacy and safety. There is uniform agreement that vasomotor instability and vaginal atrophy are totally reversible with HRT.
L E, Nachtigall, M J, Nachtigall
openaire +2 more sources
Maturitas, 1979
This study investigated the influence of hormone therapy on affect in a double blind crossover trail. The sample consisted of 49 women who had previously undergone hysterectomy and bilateral oophorectomy. Therapy consisted of 3 mth each of ethynyl oestradiol-50 micron/day, levonorgestrel-250 micron/day, "Nordial"-a combination of these two substances ...
L, Dennerstein +3 more
openaire +2 more sources
This study investigated the influence of hormone therapy on affect in a double blind crossover trail. The sample consisted of 49 women who had previously undergone hysterectomy and bilateral oophorectomy. Therapy consisted of 3 mth each of ethynyl oestradiol-50 micron/day, levonorgestrel-250 micron/day, "Nordial"-a combination of these two substances ...
L, Dennerstein +3 more
openaire +2 more sources
Hormone Therapy: Menopausal Hormone Therapy.
FP essentials, 2023The marked decrease in estrogen levels in menopausal women can cause bothersome symptoms that affect daily life. More than 75% of women experience menopausal symptoms, which can include vaginal dryness, itching, discharge, dyspareunia, mood changes, hot flushes, and night sweats.
openaire +1 more source
Clinical Obstetrics & Gynecology, 2008
Available biochemical and clinical data are sufficiently compelling to recommend low dose or transdermal hormone therapy for the management of menopausal symptoms when possible. Women initiating low dose or transdermal hormone therapy are not at increased risk of cardiovascular disease, stroke, venous thrombotic disease, and breast cancer.
openaire +2 more sources
Available biochemical and clinical data are sufficiently compelling to recommend low dose or transdermal hormone therapy for the management of menopausal symptoms when possible. Women initiating low dose or transdermal hormone therapy are not at increased risk of cardiovascular disease, stroke, venous thrombotic disease, and breast cancer.
openaire +2 more sources
Seminars in Cutaneous Medicine and Surgery, 2008
Acne affects more than 40 million people, of which more than half are women older than 25 years of age. These women frequently fail traditional therapy and have high relapse rates even after isotretinoin. Recent advances in research have helped to delineate the important role hormones play in the pathogenesis of acne.
Rosalyn, George +2 more
openaire +2 more sources
Acne affects more than 40 million people, of which more than half are women older than 25 years of age. These women frequently fail traditional therapy and have high relapse rates even after isotretinoin. Recent advances in research have helped to delineate the important role hormones play in the pathogenesis of acne.
Rosalyn, George +2 more
openaire +2 more sources
Compliance with hormone therapy
American Journal of Obstetrics and Gynecology, 1987The analysis of compliance with hormonal replacement therapy in postmenopausal women must take into account the physician's knowledge of and willingness to prescribe such treatment and the patient's acceptance of the risks and benefits. Studies have shown that most women receiving oral therapy take their medication only sporadically, and those who ...
openaire +2 more sources
Journal of the American Academy of Orthopaedic Surgeons, 2004
An estimated 10 million women in the United States currently use hormone replacement therapy (HRT) for relief of menopausal symptoms or prevention of chronic disease conditions such as osteoporosis. 1 However, the early termination of the Women’s Health Initiative (WHI) study, which examined the use of estrogen as primary prevention for osteoporosis ...
Heather V, Lochner, Thomas A, Einhorn
openaire +2 more sources
An estimated 10 million women in the United States currently use hormone replacement therapy (HRT) for relief of menopausal symptoms or prevention of chronic disease conditions such as osteoporosis. 1 However, the early termination of the Women’s Health Initiative (WHI) study, which examined the use of estrogen as primary prevention for osteoporosis ...
Heather V, Lochner, Thomas A, Einhorn
openaire +2 more sources
Breast Cancer, 2002
Recently, the guidelines for adjuvant hormonal therapy for primary breast cancer were presented at the National Institute of Health Consensus Development Conference in November 2000 and at the 7th International Conference on Adjuvant Therapy of Primary Breast Cancer in February 2001. Adjuvant hormonal therapy should be offered basically to all patients
Yasuhiro, Tamaki +2 more
openaire +2 more sources
Recently, the guidelines for adjuvant hormonal therapy for primary breast cancer were presented at the National Institute of Health Consensus Development Conference in November 2000 and at the 7th International Conference on Adjuvant Therapy of Primary Breast Cancer in February 2001. Adjuvant hormonal therapy should be offered basically to all patients
Yasuhiro, Tamaki +2 more
openaire +2 more sources
Current Opinion in Chemical Biology, 1999
Hormone replacement therapy is increasingly being used for purposes unrelated to the alleviation of menopausal symptoms, such as the prevention of osteoporosis and cardiovascular disease. Clinical trials, however, suggest that the one drug/many purposes concept may be too optimistic.
T, Kooistra, J J, Emeis
openaire +2 more sources
Hormone replacement therapy is increasingly being used for purposes unrelated to the alleviation of menopausal symptoms, such as the prevention of osteoporosis and cardiovascular disease. Clinical trials, however, suggest that the one drug/many purposes concept may be too optimistic.
T, Kooistra, J J, Emeis
openaire +2 more sources
HORMONAL THERAPY AND CHOLELITHIASIS
Obstetrical & Gynecological Survey, 1977This report is to alert the abdominal surgeon to a new factor responsible for a rising incidence of cholelithiasis in the younger woman. The cause of cholelithiasis has been explained on the basis of biochemical changes with mechanical obstruction. The role of estrogen-progesterone elevation in pregnancy with associated hypercholesteremia is well-known.
G N, Weiss, E B, Weiss
openaire +2 more sources